AstraZeneca is looking at plans to spin off its Chinese businesses to protect it from geopolitical tension, according to a report.
Citing people familiar with the situation, the Financial Times said the British-Swedish drugs giant has been in talks with bankers for several months.The plan would separate Astra’s Chinese operations into a separate company whose shares would be ...
Sverige Senaste nytt, Sverige Rubriker
Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.
AstraZeneca drafts plan to spin off China business amid tensionsAnglo-Swedish drugmaker views listing a separate unit in Hong Kong as potential shelter from global strife via IrishTimesBiz
Läs mer »